Please provide your email address to receive an email when new articles are posted on . The Eyhance monofocal IOL showed better tolerance to induced astigmatism than a standard monofocal IOL. This can ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. BARCELONA, Spain — Patients implanted with the Tecnis ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...
SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.
Center for Sight is now offering cataract patients treatment with the TECNIS Eyhance Intraocular Lens (IOL). The lens, developed by Johnson & Johnson Vision, is a next-generation monofocal lens for ...